- Report
- December 2024
- 88 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 43 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 64 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1812EUR$2,000USD£1,562GBP
- Report
- December 2024
- 60 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 66 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 157 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 75 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 79 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 90 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 105 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 60 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 80 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 66 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 91 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 99 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 90 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 144 Pages
Global
From €3578EUR$3,950USD£3,084GBP
- Report
- December 2024
- 30 Pages
Global
From €2944EUR$3,250USD£2,538GBP
- Report
- December 2024
- 102 Pages
Global
From €3578EUR$3,950USD£3,084GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more